D1-like dopamine receptor-mediated function in congenic mutants with D1 vs. D5 receptor "knockout"

Journal of Receptors and Signal Transduction

Volumn 24, Issue 3, 2004, Pages 107-116

  O'Sullivan, Gerard J ^a   Clifford, Jeremiah J ^a   Tomiyama, Katsunori ^b   Koshikawa, Noriaki ^b   Drago, John ^c   Sibley, David R ^d   Croke, David T ^a   Waddington, John L ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b NIHON UNIVERSITY   (Japan)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Behavior; Compensation processes; D1 receptor "knockout"; D1 like dopamine receptors; D5 receptor "knockout"; Ethological assessment; Genetic background

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; RECEPTOR SUBTYPE; DRD5 PROTEIN, MOUSE;

ANIMAL MODEL; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; FACE MUSCLE; GENE DELETION; HABITUATION; MOUSE; MOVEMENT (PHYSIOLOGY); NONHUMAN; PHENOTYPE; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CONGENIC STRAIN; EXPLORATORY BEHAVIOR; GENETICS; MOUSE MUTANT; PHYSIOLOGY;

ANIMALIA;

ANIMALS; BEHAVIOR, ANIMAL; EXPLORATORY BEHAVIOR; HABITUATION, PSYCHOPHYSIOLOGIC; MICE; MICE, CONGENIC; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5;

EID: 16644397785     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1081/RRS-200032078     Document Type: Conference Paper

References (37)

1. Di Chiara G. Handbook of Experimental Pharmacology: dopamine in the CNS. Heidelberg: Springer, 2002.
2. Sidhu A, Laruelle M, Vernier P. Dopamine Receptors and Transporters. New York: Marcel Dekker, 2003.
3. Sibley DR. New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 1999; 39:313-341.
4. Waddington JL, Clifford JJ, McNamara FN, Tomiyama K, Koshikawa N, Croke DT. The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout'). Prog Neuropsychopharmacol Biol Psychiatry 2001; 25:925-964.
5. Glickstein SB, Schmauss C. Dopamine receptor function: lessons from knockout mice. Pharmacol Ther 2001; 91:63-83.
6. Tan S, Hermann B, Borrelli E. Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. Int Rev Neurobiol 2003; 54:145-197.
7. Waddington JL. Behavioural correlates of the action of selective D-1 dopamine receptor antagonists: the impact of SCH 23390 and SK&F 83566, and functionally interactive D-1:D-2 receptor systems. Biochem Pharmacol 1986; 35:3661-3667.
8. Waddington JL, O'Boyle KM. Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. Pharmacol Ther 1989; 43:1-52.
9. Waddington JL, Daly SA, McCauley PG, O'Boyle KM. Levels of functional interaction between D1-like and D2-like dopamine receptor systems. In: Niznik HB, ed. Dopamine Receptors and Transporters. New York: Marcel Dekker, 1994:511-537.
10. Waddington JL, Daly SA, Downes RP, Deveney AM, McCauley PG, O'Boyle KM. Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19:811-831.
11. Niznik HB, Sugamori KS, Clifford JJ, Waddington JL. D1-like dopamine receptors: molecular biology and pharmacology. In: Di Chiara G, ed. Handbook of Experimental Pharmacology: dopamine in the CNS. Heidelberg: Springer, 2002:121-158.
12. Apostolakis EM, Garai J, Fox C, Smith CL, Watson SJ, Clark JH, O'Malley BW Dopaminergic regulation of progesterone receptors: brain D5 dopamine receptors mediate induction of lordosis by D1-like agonists in rats. J Neurosci 1996; 16:4823-4834.
13. 5, but not progestin receptor, antagonist and anti-sense oligonucleotide infusions to the ventral tegmental area of cycling rats and hamsters attenuate lordosis. Behav Brain Res 1999; 103:23-34.
14. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, Ooi GT, Grinberg A, Lee EJ, Huang SP, Bartlett PF, Jose PA, Sibley DR, Westphal H. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA 1994; 91:12564-12568.
15. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994; 79:729-742.
16. McNamara FN, Clifford JJ, Tighe O, Kinsella A, Drago J, Croke DT, Waddington JL. Congenic D(1A) Dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype. Neuropsychopharmacology 2003; 28:86-99.
17. Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 1994; 79:945-955.
18. Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP, Gallagher M. Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 1998; 86:135-146.
19. Clifford JJ, Tighe O, Croke DT, Sibley DR, Drago J, Waddington JL. Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology 1998; 37:1595-1602.
20. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, Hitzemann RJ, Maxson SC, Miner LL, Silva AJ, Wehner JM, Wynshaw-Boris A, Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 1997; 132:107-124.
21. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G, Bunzow JR, Fang Y, Gerhardt GA, Grandy DK, Low MJ. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 1998; 18:3470-3479.
22. Phillips TJ, Hen R, Crabbe JC. Complications associated with genetic background effects in research using knockout mice. Psychopharmacology 1999; 147:5-7.
23. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, Barlow C. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA 2000; 97:11038-11043.
24. Sanford LP, Kallapur S, Ormsby I, Doetschman T. Influence of genetic background on knockout mouse phenotypes. In: Tymms MJ, Kola I, eds. Gene Knockout Protocols. Totowa, NJ: Humana Press, 2001:217-226.
25. Clifford JJ, Kinsella A, Tighe O, Rubinstein M, Grandy DK, Low MJ, Croke DT, Waddington JL. Comparative, topographically-based evaluation of behavioural phenotype and specification of D1-like:D2-like interactions in a line of incipient congenic mice with D2 dopamine receptor 'knockout'. Neuropsychopharmacology 2001; 25:527-536.
26. Crabbe JC, Wahlsten D, Dudek BC. Genetics of mouse behavior: interactions with laboratory environment. Science 1999; 284:1670-1672.
27. Tomiyama K, McNamara FN, Clifford JJ, Kinsella A, Drago J, Tighe O, Croke DT, Koshikawa N, Waddington JL. Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor 'knockout' mice. Neuropharmacology 2002; 42:644-652.
28. Tomiyama K, McNamara FN, Clifford JJ, Kinsella A, Koshikawa N, Waddington JL. Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D(1)-like vsD(2)-like receptor regulation. Eur J Pharmacol 2001; 418:47-54.
29. Waddington JL. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology and putative relationship to tardive dyskinesia. Psychopharmacology 1990; 101:431-447.
30. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 2002; 22:10801-10810.
31. Holmes A, Hollon TR, Gleason TC, Liu Z, Dreiling J, Sibley DR, Crawley JN. Behavioral characterization of dopamine D5 receptor null mutant mice. Behav Neurosci 2001; 115:1129-1144.
32. Elliot EE, Sibley DR, Katz JL. Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice. Psychopharmacology 2003; 169:161-168.
33. O'Sullivan GJ, Croke DT, Tighe O, Kinsella A, Grandy DK, Low M, Rubinstein M, Sibley DR, Waddington JL. Topographical evaluation of spontaneous and agonist-induced behaviour in mutants with congenic dopamine D4 versus D5 receptor knockout. Eur Neuropsychopharmacol 2004, 13(Suppl 1):S41.
34. Makihara Y, Yamamoto H, Grandy D, Low M, Rubinstein M, Sibley DR, Waddington JL, Tomiyama K, Koshikawa N. Roles of dopamine receptor subtypes on the regulation of orofacial movements using D4 and D5 receptor knockout mice. Folia Pharmacol Japn 2003; 122:25P.
35. Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2:165-174.
36. Kido Y, Philippe N, Schaffer AA, Accilli D Genetic modifiers of the insulin resistance phenotype in mice. Diabetes 2000; 49:589-596.
37. Lariviere WR, Chesler EJ, Mogil JS. Transgenic studies of pain and analgesia: mutation or background genotype? J Pharmacol Exp Ther 2001; 297:467-473.